January 16, 2018 / 1:15 PM / a month ago

BRIEF-ARMO Biosciences Sees IPO Of Up To 6.7 Mln Shares Of Common Stock, Estimated IPO Price Between $14 And $16/Shr

Jan 16 (Reuters) -

* ARMO BIOSCIENCES INC SEES IPO OF UP TO 6.7 MILLION SHARES OF COMMON STOCK AND ESTIMATED IPO PRICE BETWEEN $14.00 AND $16.00 PER SHARE - SEC FILING

* ARMO BIOSCIENCES - INTENDS TO USE ABOUT $35 MILLION OF IPO PROCEEDS TO FUND DEVELOPMENT OF AM0010 FOR TREATMENT OF PDAC, INCLUDING PHASE 3 CLINICAL TRIAL

* ARMO BIOSCIENCES - INTENDS TO USE ABOUT $35 MILLION OF IPO PROCEEDS TO FUND TWO PLANNED PHASE 2B CLINICAL TRIALS IN NSCLC Source text: (bit.ly/2FGsF7g)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below